Biological Fermentation Products: Sialic Acid, Curdlan, Gellan Gum, DHA Algal Oil, DHA Algal Oil Powder, β-Nicotinamide Mononucleotide (NMN), γ‑Aminobutyric Acid (GABA)
Plant Extracts: Yam Powder, Mulberry Leaf Extract, Grape Seed Extract, Ginkgo Biloba Extract, Schizochytrium Meal, Rhodiola Rosea Extract, Mulberry Fruit Extract, Icariin
Shandong Holy Leaf Biotechnology Co., Ltd. (山东天智绿业生物科技有限公司) is a high-tech biotechnology enterprise based in Heze, Shandong Province, China, specializing in the research, development, production, and sale of high-value biological fermentation products and plant extracts. With a focus on health-oriented and functional ingredients, the company has established itself as a key player in China's nutraceutical and bio-ingredient supply chain.
The company's primary business revolves around biotechnological innovation using microbial fermentation and natural extraction techniques. Their product portfolio spans two major categories:
Biological Fermentation Products
Plant Extracts
These ingredients are widely used in dietary supplements, functional foods, pharmaceuticals, and cosmetics, addressing global demands for natural, safe, and bioactive substances.
Shandong Holy Leaf’s core specialization lies in precision fermentation and extraction technologies. The company utilizes advanced bioreactor systems and enzymatic processes to ensure product purity and high bioavailability. Their USP includes:
Their focus on “green biotech” and sustainable sourcing has positioned the brand favorably in international markets where compliance with organic, vegan, and clean-label trends is critical.
Holy Leaf serves both domestic and international markets, with primary export destinations including:
The company caters to industries such as:
Shandong Holy Leaf operates a modern production facility equipped with:
Its R&D division collaborates with several universities and biotech research institutions in China to co-develop novel bioactive compounds and improve fermentation yields.
While specific certifications are not publicly listed, the company emphasizes adherence to international standards including:
Their products, particularly DHA algal oil and NMN, are positioned to meet export-oriented regulatory frameworks such as the FDA's GRAS and EU Novel Food requirements.
Although financial figures are not publicly disclosed, third-party trade data platforms such as ImportYeti and Volza indicate consistent outbound shipments of NMN, GABA, and plant extract powders from Shandong Holy Leaf to nutraceutical manufacturers and distributors globally.
For example, ImportYeti data shows shipment activity to several U.S.-based supplement firms between 2022 and 2024, with consignment sizes ranging from 500kg to 2 metric tons, particularly for NMN and GABA powders.
This aligns with the growing global demand for anti-aging and neurological health compounds.
Shandong Holy Leaf Biotechnology Co., Ltd. continues to scale its operations while investing in cutting-edge bioscience to deliver innovative, clean-label, and sustainable health ingredients to the global market.
